Medra
Autonomous labs to generate life science data
Autonomous labs to generate life science data. Listed on Harmonic's Hot 25 (Q2 2026 #21); best rank #21 in Q2 2026. Harmonic headcount ~35.
Biotech
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Medra going public?
No. Medra is private and has not filed to go public. There is no S-1 on file.
What is Medra's valuation in 2026?
No confirmed valuation is on record for Medra. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Medra filed an S-1?
No public S-1 is on file for Medra.
Can you buy Medra stock?
No. Medra is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Medra on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Last Round
Series A — $52M (Dec 2025)
Fundraising Status
Series A · $52M · 9 mo ago
private1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series A | $52M | Dec 2025 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Biotech / Gene Therapy registry data for Medra has not been collected yet — the weekly vertical sweep hasn't reached this company. Check back soon.
Talent Signal
Hiring data for Medra has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
Competitors
periodic-labs · lila-sciences
AIBiotechAutonomous LabsLife Sciences
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.